← Back to Patent Explorer
US4038399A Expired / Lapsed US ⏱️ 0.0 years remaining

1,4-dihydropyridine carboxylic acid esters useful as coronary vessel dilators and anti-hypertensives

Assignee: Bayer AG
•
Filing: 1976-01-08
•
Granted: 1977-07-26
•
Expires: 1996-01-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1,4-DINYDROPYRIDINE CARBOXYLIC ACID ESTERS OF THE FORMULA: ##STR1## or a pharmaceutically acceptable nontoxic salt thereof wherein R, R 1 R 2 R 3 R 4 X and Y are defined hereinafter Are useful for their coronary activity, particularly as coronary vessel dilators and as antihypertensives.

Inventors

  • 👤 Friedrich Bossert
  • 👤 Horst Meyer
  • 👤 Wulf Vater

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 21:49
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/04; C07D401/14; C07D405/00; C07D405/14; C07D409/00; C07D409/14

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 170 words
A pharmaceutical composition useful for effecting coronary vessel dilation in humans and animals and for treating hypertension in humans and animals which comprises a coronary vessel dilating amount or an antihypertensive amount of a compound of the formula: ##STR69## or a pharmaceutically acceptable nontoxic salt thereof wherein R is hydrogen, straight- or branched-chain lower alkyl, lower alkenyl or lower alkynyl; R 1 and R 4 are the same or different and are each hydrogen or straight- or branched-chain lower alkyl; X is straight- or branched-chain lower alkylene; Y is the moiety NR'R" wherein R' and R" are the same or different and are each hydrogen or lower alkyl; R 2 is phenyl unsubstituted or substituted by 1, 2 or 3 substituents selected from the group consisting of nitro, cyano, lower alkyl, lower alkoxy, phenyl, trifluoromethyl and halogen; benzyl; phenyl-ethyl; styryl; or naphthyl; and R 3 is alkoxyalkyl of up to 6 carbon atoms in both moieties; lower alkyl; or lower alkoxy; in combination with a pharmaceutically acceptable diluent or carrier.
Claim 2
Dependent Claim 170 words
A pharmaceutical composition useful for effecting coronary vessel dilation in humans and animals and for treating hypertension in humans and animals which comprises a coronary vessel dilating amount or an antihypertensive amount of a compound of the formula: ##STR69## or a pharmaceutically acceptable nontoxic salt thereof wherein R is hydrogen, straight- or branched-chain lower alkyl, lower alkenyl or lower alkynyl; R 1 and R 4 are the same or different and are each hydrogen or straight- or branched-chain lower alkyl; X is straight- or branched-chain lower alkylene; Y is the moiety NR'R" wherein R' and R" are the same or different and are each hydrogen or lower alkyl; R 2 is phenyl unsubstituted or substituted by 1, 2 or 3 substituents selected from the group consisting of nitro, cyano, lower alkyl, lower alkoxy, phenyl, trifluoromethyl and halogen; benzyl; phenyl-ethyl; styryl; or naphthyl; and R 3 is alkoxyalkyl of up to 6 carbon atoms in both moieties; lower alkyl; or lower alkoxy; in combination with a pharmaceutically acceptable diluent or carrier.
Claim 3
Dependent Claim 132 words
A composition according to claim 1 wherein R is hydrogen, straight- or branched-chain alkyl of 1 to 4 carbon atoms or straight- or branched-chain alkenyl of 2 to 4 carbon atoms; R 1 and R 4 are the same or different and are each hydrogen or straight- or branched-chain alkyl of 1 to 4 carbon atoms; X is straight- or branched-chain alkylene of 1 to 4 carbon atoms; R' and R" are the same or different and are each hydrogen or alkyl of 1 to 4 carbon atoms; and R 2 is phenyl unsubstituted or substituted by 1 or 2 nitro, cyano, alkyl of 1 to 4 carbon atoms, chloro, bromo or trifluoromethyl groups, or by 1 to 3 alkoxy groups of 1 to 4 carbon atoms; benzyl; phenyl-ethyl; styryl; or naphthyl.
Claim 4
Dependent Claim 34 words
A composition according to claim 1 wherein the alkyl moiety of R has 1 to 3 carbon atoms and the alkyl moiety of R 1 and R 4 has 1 or 2 carbon atoms.
Claim 5
Dependent Claim 21 words
A composition according to claim 3 wherein R 2 is pbenyl unsubstituted or substituted by nitro, cyano, chloro, bromo or trifluoromethyl.
Claim 6
Dependent Claim 84 words
A composition according to claim 1 wherein R is hydrogen or straight- or branched-chain alkyl of 1 to 4 carbon atoms, R 1 and R 4 are the same or different and are each straight- or branched-chain alkyl of 1 to 4 carbon atoms, X is straight- or branched-chain alkylene of 1 to 4 carbon atoms, Y is dimethylamino or diethylamino; and R 2 is phenyl; phenyl substituted by 1 or 2 substituents selected from the group consisting of nitro, cyano, chloro and trifluoromethyl.
Claim 7
Dependent Claim 100 words
A composition according to claim 1 wherein R is hydrogen or straight- or branched-chain alkyl of 1 to 4 carbon atoms, R 1 is straight- or branched-chain alkyl of 1 to 3 carbon atoms, R 4 is straight- or branched-chain alkyl of 1 to 4 carbon atoms, X is straight- or branched-chain alkylene of 1 to 3 carbon atoms, Y is dimethylamino or diethylamino, R 2 is phenyl; phenyl substituted by nitro, nitro and trifluoromethyl, nitro and chloro, dinitro, trifluoromethyl, di-trifluoromethyl, chloro, dichloro, cyano or fluoro; and R 3 is straight- or branched-chain alkoxy of 1 to 4 carbon atoms.
Claim 8
Dependent Claim 25 words
A composition according to claim 1 wherein R is hydrogen or lower alkyl; and R 2 is phenyl unsubstituted by nitro, cyano, trifluoromethyl or halogen.
Claim 9
Dependent Claim 63 words
A composition according to claim 1 wherein R is hydrogen; R 1 and R 4 are each lower alkyl; R' and R" are different and are selected from the group consisting of hydrogen and lower alkyl; R 2 is phenyl unsubstituted or substituted by nitro, cyano, trifluoromethyl or halogen; and R 3 is alkoxyalkyl of up to 6 carbon atoms in both moieties.
Claim 10
Dependent Claim 16 words
The composition according to claim 1 wherein the compound is 1,2,6-trimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(β-diethylamine)-ethyl ester 5-methyl ester.
Claim 11
Dependent Claim 16 words
The composition according to claim 1 wherein the compound is 1,2,6-trimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(γ-dimethylamino)-propyl ester 5-ethyl ester.
Claim 12
Dependent Claim 16 words
The composition according to claim 1 wherein the compound is 2,6-dimethyl-4-(2'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(γ-dimethylamino)-propyl ester 5-methyl ester.
Claim 13
Independent Claim 173 words
A method of effecting coronary vessel dilation in humans and animals and of treating hypertension in humans and animals which comprises administering to such human or animal a coronary vessel dilating amount or an antihypertensive amount of a compound of the formula ##STR70## or a pharmaceutically acceptable nontoxic salt thereof wherein R is hydrogen, straight- or branched-chain lower alkyl, lower alkenyl or lower alkynyl; R 1 and R 4 are the same or different and are each hydrogen or straight- or branched-chain lower alkyl; X is straight- or branched-chain lower alkylene; Y is the moiety NR'R" wherein R' and R" are the same or different and are each hydrogen or lower alkyl; R 2 is phenyl unsubstituted or substituted by 1, 2 or 3 substituents selected from the group consisting of nitro, cyano, lower alkyl, lower alkoxy, phenyl, trifluoromethyl and halogen; benzyl; phenyl-ethyl; styryl; and R 3 is alkoxyalkyl of up to 6 carbon atoms in both moieties; lower alkyl; or lower alkoxy; in combination with a pharmaceutically acceptable nontoxic diluent or carrier.
Claim 14
Independent Claim 173 words
A method of effecting coronary vessel dilation in humans and animals and of treating hypertension in humans and animals which comprises administering to such human or animal a coronary vessel dilating amount or an antihypertensive amount of a compound of the formula ##STR70## or a pharmaceutically acceptable nontoxic salt thereof wherein R is hydrogen, straight- or branched-chain lower alkyl, lower alkenyl or lower alkynyl; R 1 and R 4 are the same or different and are each hydrogen or straight- or branched-chain lower alkyl; X is straight- or branched-chain lower alkylene; Y is the moiety NR'R" wherein R' and R" are the same or different and are each hydrogen or lower alkyl; R 2 is phenyl unsubstituted or substituted by 1, 2 or 3 substituents selected from the group consisting of nitro, cyano, lower alkyl, lower alkoxy, phenyl, trifluoromethyl and halogen; benzyl; phenyl-ethyl; styryl; and R 3 is alkoxyalkyl of up to 6 carbon atoms in both moieties; lower alkyl; or lower alkoxy; in combination with a pharmaceutically acceptable nontoxic diluent or carrier.
Claim 15
Dependent Claim 132 words
A method according to claim 12 wherein R is hydrogen, straight- or branched-chain alkyl of 1 to 4 carbon atoms or straight- or branched-chain alkenyl of 2 to 4 carbon atoms; R 1 and R 4 are the same or different and are each hydrogen or straight- or branched-chain alkyl of 1 to 4 carbon atoms; X is straight- or branched-chain alkylene of 1 to 4 carbon atoms; R' and R" are the same or different and are each hydrogen or alkyl of 1 to 4 carbon atoms; and R 2 is phenyl unsubstituted or substituted by 1 or 2 nitro, cyano, alkyl of 1 to 4 carbon atoms, chloro, bromo or trifluoromethyl groups, or by 1 to 3 alkoxy groups of 1 to 4 carbon atoms; benzyl; phenyl-ethyl; styryl; or naphthyl.
Claim 16
Dependent Claim 34 words
A method according to claim 12 wherein the alkyl moiety of R has 1 to 3 carbon atoms and the alkyl moiety of R 1 and R 4 has 1 or 2 carbon atoms.
Claim 17
Dependent Claim 21 words
A method according to claim 12 wherein R 2 is phenyl unsubstituted or substituted by nitro, cyano, chloro, bromo or trifluoromethyl.
Claim 18
Dependent Claim 84 words
A method according to claim 12 wherein R is hydrogen or straight- or branched-chain alkyl of 1 to 4 carbon atoms, R 1 and R 4 are the same or different and are each straight or branched-chain alkyl of 1 to 4 carbon atoms, X is straight- or branched-chain alkylene of 1 to 4 carbon atoms, Y is dimethylamino or diethylamino; and R 2 is phenyl, phenyl substituted by 1 or 2 substituents selected from the group consisting of nitro, cyano, chloro and trifluoromethyl.
Claim 19
Dependent Claim 102 words
A method according to claim 12 wherein R is hydrogen or straight- or branched-chain alkyl of 1 to 4 carbon atoms, R 1 is straight- or branched-chain alkyl of 1 to 3 carbon atoms, R 4 is straight- or branched-chain alkyl of 1 to 4 carbon atoms, X is straight- or branched-chain alkylene of 1 to 3 carbon atoms, Y is dimethylamino or diethylamino, R 2 is phenyl; phenyl substituted by nitro, nitro and trifluoromethyl, nitro and chloro, dinitro, trifluoromethyl, di-trifluoromethyl, chloro, dichloro, cyano or fluoro; and R 3 is straight- or branched-chain alkoxy of 1 to 4 carbon atoms or methoxyethoxy.
Claim 20
Dependent Claim 27 words
A method according to claim 12 wherein R is hydrogen or lower alkyl; and R 2 is phenyl unsubstituted or substituted by nitro, cyano, trifluoromethyl or halogen.
Claim 21
Dependent Claim 63 words
A method according to claim 12 wherein R is hydrogen; R 1 and R 4 are each lower alkyl; R' and R" are different and are selected from the group consisting of hydrogen and lower alkyl; R 2 is phenyl unsubstituted or substituted by nitro, cyano, trifluoromethyl or halogen; and R 3 is alkoxyalkyl of up to 6 carbon atoms in both moieties.
Claim 22
Dependent Claim 17 words
A method according to claim 12 wherein the compound is 1,2,6,-trimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(β -diethylamine)-ethyl ester 5-methyl ester.
Claim 23
Dependent Claim 16 words
A method according to claim 12 wherein the compound is 1,2,6-trimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3(γ-dimethylamino)-propyl ester 5-ethyl ester.
Claim 24
Dependent Claim 16 words
A method according to claim 12 wherein the compound is 2,6-dimethyl-4-(2'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(γ-dimethylamino)-propyl ester 5-methyl ester.

References Cited (Backward Citations)

US3488359A Cited
US3905970A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-07-25 1981-01-24 1981-07-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-07-25 1985-01-24 1985-07-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-07-25 1989-01-24 1989-07-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag